General MedicationsINJECTIONGeneric
PYOPEN
CARBENICILLIN DISODIUM
Standard Dose
EQ 20GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview PYOPEN is listed in Drugs@FDA under application 050298 (NDA).
Marketing status: Discontinued Active ingredient CARBENICILLIN DISODIUM Form and strength INJECTABLE;INJECTION - EQ 20GM BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview PYOPEN is listed in Drugs@FDA under application 050298 (NDA). Marketing status: Discontinued Active ingredient CARBENICILLIN DISODIUM Form and strength INJECTABLE;INJECTION - EQ 20GM BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.